Overview

PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

Status:
Completed
Trial end date:
2017-04-23
Target enrollment:
Participant gender:
Summary
Primary Objective: Pharmacodynamics: assessment by pH metry of the change in gastric pH (antacid activity) of Z0063, in comparison to the effect of Gaviscon Double Action Tablets, in healthy adult subjects. Secondary Objective: Safety: assessment of the clinical safety of Z0063, and Gaviscon Double Action Tablets, in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi
Treatments:
Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
Almagate
Aluminum Hydroxide
Antacids
Magnesium Hydroxide